SLCO1B1基因基因临床决策支持降低了与simvastatin相关的他类药物肌肉症状风险
Amanda Massmann1,2, Joel Van Heukelom1,2, Robert C Green3,4,5
1Sanford Imagenetics, Sanford Health, Sioux Falls, SD 57105, USA.
Pharmacogenomics
|May 26, 2023
概括
临床决策支持 (CDS) 警报显著减少了SLCO1B1变异患者的simvastatin处方,降低了与他类药物相关的肌肉症状 (SAMS) 的风险. 这种遗传信息提高了处方安全性.
科学领域:
- 药物基因组学 药物基因组学
- 临床信息学 临床信息学
背景情况:
- SLCO1B1变种已被确立为他类药物相关肌肉症状 (SAMS) 风险的预测因素,特别是在simvastatin.
- 对SLCO1B1的基因测试可以为个性化他类药物治疗提供信息.
研究的目的:
- 评估临床决策支持 (CDS) 系统在基于SLCO1B1基因型的simvastatin处方管理中的有效性.
- 量化CDS警报对SAMS风险降低的吸收和影响.
主要方法:
- 对20341名SLCO1B1基因定型患者的回顾性图表审查.
- 分析CDS警报生成和提供者对遗传信息的响应.
主要成果:
- 对182名患者产生了417个CDS警报,82.4%的患者接受了适当的药物治疗.
- 当基因型鉴定在处方之前 (94.1%与28.5%) 时,对Simvastatin的订单更频繁地被取消.
结论:
- 通过将CDS与SLCO1B1基因定型集成,有效地减少了处方高风险的simvastatin剂量.
- 积极的基因查和CDS警报提高了药物安全性和SAMS预防.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
717
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
717
Atherosclerosis III: Management
16
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
16
Classification of Skeletal Muscle Relaxants
2.5K
Skeletal muscle relaxants are a group of drugs that can reduce muscle stiffness and induce temporary paralysis to relieve pain. These agents can act centrally to reduce muscle tone or spasms in painful conditions such as multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), or spinal injuries; they are called antispasmodics or spasmolytics.
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
Peripherally acting skeletal muscle relaxants interfere with the neurotransmission at the neuromuscular end plate to induce paralysis during...
2.5K
Cholesterol: Significance and Regulation
609
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
609
Atherosclerosis IV: Nursing Management
29
Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
29
Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25


